Aastrom Biosciences, Inc.
Grant will fund the extension of adult stem cell process to other tissues
Published in Pharma Investments, Ventures and Law Weekly, September 18th, 2005
The 2-year phase II grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) totals $740,000, of which $324,000 has been received for the first year of this study. This phase II grant award follows a phase I grant issued to Aastrom in 2003 by the NIH's National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Aastrom's Tissue Repair Cells (TRCs), a bone marrow-derived adult...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Access Pharmaceuticals, Inc.
Pharmaceutical company announces financing arrangement - Actavis
Pharma company appoints chief executive of finance - Acusphere, Inc.
Pharmaceutical firm spends $8.4M to build out facility for drug manufacturing - Adherex Technologies, Inc.
Pharmaceutical firm reports loss of $0.13 per share - Adventrx Pharmaceuticals, Inc.
Pharmaceutical firm posts loss of $0.06 per share - Alder Biopharmaceuticals, Inc.
Biopharmaceutical company raises $11.1M in series A financing - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
